Tech Company Financing Transactions
CV6 Therapeutics Funding Round
CV6 Therapeutics closed a $9.2 million venture capital round on 11/3/2022. Investors included Co-FundNI, Invest Northern Ireland and QUBIS.
Transaction Overview
Company Name
Announced On
11/3/2022
Transaction Type
Venture Equity
Amount
$9,200,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to progress its oncology asset CV6-168 into a Phase 1a clinical trial and perform further scientific development work.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Centre for Cancer Research & Cell Biology 97 Lisburn Road
Belfast, BT9 7AE
UK
Belfast, BT9 7AE
UK
Phone
Website
Email Address
Overview
CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel combination therapies. Over the last 25 years, our research has focused on identifying molecular vulnerabilities in cancer cells that can be targeted with novel and innovative therapeutics. This research led to the identification of novel drug targets that now form the basis of innovative strategies designed to significantly improve the current treatment options for cancer and improve the lives of patients and their families.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Richard Milliken
Chief Executive Officer
Robert Ladner
Chief Operating Officer
Karl Mulligan
Browse more venture capital transactions:
Prev: 11/3/2022: Momento venture capital transaction
Next: 11/3/2022: ConstellR venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs